Sage Therapeutics Inc. (SAGE)
NASDAQ: SAGE
· Real-Time Price · USD
8.68
0.00 (0.00%)
At close: Jul 30, 2025, 3:59 PM
Sage Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -301.19M | -354.4M | -400.67M | -337.59M | -445.67M | -503.14M | -541.49M | -655.93M | -591.62M | -557.56M | -532.78M | -510.35M | -503.2M | -484.18M | -457.89M | 641.72M | 666.15M | 637.05M |
Depreciation & Amortization | -1.04M | -286K | 1.03M | 1.31M | 1.39M | 1.41M | 1.39M | 1.27M | 1.22M | 1.17M | 1.12M | 1.17M | 1.26M | 1.88M | 4.18M | 4.5M | 4.77M | 4.54M |
Stock-Based Compensation | 39.3M | 47.73M | 54.5M | 58.02M | 72.5M | 67.03M | 73.37M | 75.67M | 60.14M | 63.09M | 61.6M | 67.01M | 88.18M | 101.21M | 104.63M | 104.72M | 90.49M | 86.86M |
Other Working Capital | 14.72M | 802K | 8.51M | -106.41M | -71.88M | -51.9M | -34.88M | 64.84M | 27.12M | 7.45M | -2.76M | 3.09M | 24.7M | 479K | -25.2M | -9.77M | -41.16M | -23.39M |
Other Non-Cash Items | -45.99M | 9.78M | -46.06M | -38.84M | -41.7M | -59.13M | -6.47M | -13.96M | -7.95M | -1.2M | 4.35M | 6.19M | 6.25M | -117K | -10.6M | -11.32M | -12.68M | -8.56M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 19.58M | 1.13M | 84.76M | -42.28M | 589K | 14.82M | -67.38M | 44.95M | 7.21M | -11.42M | 5.67M | 5.38M | 26.94M | 4.32M | -18.51M | -9.33M | -40.63M | -28M |
Operating Cash Flow | -289.34M | -311.09M | -267.19M | -320.15M | -373.65M | -424.74M | -540.59M | -548M | -531M | -505.92M | -460.04M | -430.61M | -380.57M | -376.9M | -378.18M | 730.29M | 708.1M | 691.88M |
Capital Expenditures | n/a | n/a | n/a | 112K | -216K | -328K | -553K | -947K | -983K | -993K | -937K | -1.03M | -663K | -541K | -372K | 1K | n/a | -70K |
Cash Acquisitions | n/a | n/a | n/a | -41.95M | -202.67M | -248.37M | -443.47M | -491.58M | -442.17M | -530.85M | -335.76M | -245.7M | -134.38M | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -347.6M | -477.31M | -450.96M | -497.21M | -464.95M | -499.4M | -594.67M | -658.25M | -839.59M | -736M | -881.04M | -1B | -1.11B | -1.45B | -1.99B | -1.76B | -1.56B | -1.23B |
Sales Maturities Of Investments | 602.02M | 650.34M | 717.63M | 759.26M | 806.67M | 887.21M | 1.04B | 1.15B | 1.28B | 1.27B | 1.21B | 1.21B | 1.18B | 1.1B | 988.08M | 834.62M | 666.92M | 809.52M |
Other Investing Acitivies | n/a | -386K | 139.05M | 181M | 341.72M | 387.81M | 443.47M | 491.58M | 442.17M | 530.85M | 326.37M | 206.42M | 70.12M | -352.65M | -1B | -972.19M | -947.2M | -481.36M |
Investing Cash Flow | 254.43M | 173.03M | 266.68M | 262.17M | 341.5M | 387.48M | 442.91M | 490.63M | 441.19M | 529.86M | 325.43M | 205.4M | 69.46M | -353.19M | -1B | -926.67M | -888.17M | -422.4M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | 3K | 2K | n/a | -262K | -269K | -276K | -903K | -645K | -656K | -672K | -43K | -628K | -613K | -1.39M | -1.39M | -796K | -796K | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 1.12M | 9.25M | 10.66M | 10.4M | 12.14M | 4.91M | 6.03M | 6.32M | 4.78M | 3.94M | 3.07M | 2.87M | 3.46M | 9.51M | 13.33M | 15.68M | 17.4M | 11.72M |
Financial Cash Flow | 1.12M | 9.25M | 10.66M | 10.4M | 12.14M | 4.91M | 6.03M | 6.32M | 4.78M | 3.94M | 3.07M | 2.87M | 3.46M | 9.51M | 13.33M | 433.18M | 434.9M | 429.23M |
Net Cash Flow | -32.3M | -127.31M | 10.15M | -47.59M | -21.52M | -33.84M | -91.64M | -51.05M | -85.03M | 27.88M | -131.53M | -222.34M | -307.65M | -720.58M | -1.37B | 236.8M | 254.83M | 698.71M |
Free Cash Flow | -289.34M | -311.09M | -267.19M | -320.04M | -373.87M | -425.06M | -541.14M | -548.95M | -531.98M | -506.91M | -460.97M | -431.63M | -381.23M | -377.44M | -378.55M | 730.29M | 708.1M | 691.82M |